The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Uncontrolled Postviral Asthma and Persistent Symptoms After COVID-19 (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05919004
Recruitment Status : Completed
First Posted : June 26, 2023
Last Update Posted : June 28, 2023
Sponsor:
Information provided by (Responsible Party):
Tonje Reier-Nilsen, The Norwegian Sports Medicine Centre - Football Association, Oslo, Norway

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Patients with long covid referred for physical rehabilitation at the Norwegian Sports Medicine Centre - Football Association in Oslo, Norway, were assessed for postviral asthma.

Condition or disease Intervention/treatment
Long COVID Diagnostic Test: App-based spirometer

Detailed Description:
All patients performed methacholin bronchial provocation test, and those with a negative bronchial provocation were eqipped with an app-based spirometer to detect excessive lung variability. Eventual detection of postviral asthma will be treated according to GINA guidelines and eventual effect will be assessed by lung function variability and symptoms.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Uncontrolled Postviral Asthma in Patients With Long Covid
Actual Study Start Date : May 1, 2022
Actual Primary Completion Date : November 1, 2022
Actual Study Completion Date : December 31, 2022

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Diagnostic Test: App-based spirometer
    App-based spirometer to perform serial spirometry to assess lung function variatione

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Excessive lung function variation [ Time Frame: 8 months ]
    Lung function given as FEV1.

  2. Perceived symptoms of long covid [ Time Frame: 8 months ]
    On a Likert scale 1-10


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Patients with long covid for more than 6 months
Criteria

Inclusion Criteria:

° Patients with long covid for more than 6 months referred for physical rehabilitation

Exclusion Criteria:

° None

Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05919004


Locations
Layout table for location information
Norway
Idrettens Helsesenter
Oslo, Norway
Sponsors and Collaborators
The Norwegian Sports Medicine Centre - Football Association, Oslo, Norway
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Tonje Reier-Nilsen, MD PhD, The Norwegian Sports Medicine Centre - Football Association, Oslo, Norway
ClinicalTrials.gov Identifier: NCT05919004    
Other Study ID Numbers: IdrettensHelsesenter
First Posted: June 26, 2023    Key Record Dates
Last Update Posted: June 28, 2023
Last Verified: June 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Tonje Reier-Nilsen, The Norwegian Sports Medicine Centre - Football Association, Oslo, Norway:
postviral asthma
diagnosis
long covid
 telemedicine
lung function
digital spirometer
Additional relevant MeSH terms:
Layout table for MeSH terms
Post-Acute COVID-19 Syndrome
Respiratory Tract Diseases
Lung Diseases
COVID-19
Pneumonia, Viral
Pneumonia
Respiratory Tract Infections
Infections
Virus Diseases
 Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Post-Infectious Disorders
Chronic Disease
Disease Attributes
Pathologic Processes